Center Checklist

Start with what can be independently confirmed.

A center should be able to explain the business and medical structure under which it operates. Ask what registrations, permissions, or licenses apply to the facility and what professional registration or authorization applies to the physician responsible for clinical decisions. Keep the answer in writing and note whether the response identifies a specific role rather than relying on broad assurances.

Country-level context is not a substitute for a center-specific answer. Use the wider Mexico hub context to frame questions, then compare each facility’s documents, names of responsible roles, and stated procedures on their own terms. For a useful baseline on transparent decision-making and accountability, the independent resource’s stated approach may help keep the comparison focused on evidence rather than marketing language.

Follow the chain from screening to emergency transfer.

Ask how the center assesses medical history, current medications, substance use, and contraindications before acceptance. Ask whether laboratory testing and ECG review are available, who interprets results, when results are reviewed, and what changes to the plan are made when screening identifies a concern. An ECG records the heart’s electrical activity, as described by the National Heart, Lung, and Blood Institute’s ECG overview; a center should be able to state clearly how it uses such information in its workflow.

Emergency readiness is a sequence, not a slogan.

Ask whether a defibrillator is onsite and maintained, whether ACLS-trained staff are present during relevant phases of care, and what written emergency protocols direct staff to do. The American Heart Association’s resuscitation guidance illustrates why emergency systems depend on protocols, training, equipment, and coordinated response rather than a single item.

• Written pre-treatment screening and medication-review process.
• Details of laboratory and ECG access, review, and response to findings.
• Emergency equipment checks, trained-staff coverage, and a hospital referral pathway.

Make the product and care pathway specific.

Ask the center to identify what it says it administers: ibogaine, whole-iboga material, noribogaine, or another preparation. Ask how identity, source, handling, and dosing philosophy are documented; ask what monitoring occurs before, during, and after treatment; and ask what post-treatment medical and non-medical follow-up is included. Names alone do not establish consistency or safety, so written detail matters.

“A clear answer names the preparation, describes the decision process, and leaves a record a prospective patient can review.”

Ibogaine has been described in scientific and reference literature as a psychoactive alkaloid associated with the iboga plant; the Wikipedia overview of ibogaine can help distinguish basic terminology, but it cannot verify the identity or quality of a particular center’s product. Ask the center what documentation it can provide for its own process.

Pre- and post-care should be just as concrete. Ask when screening occurs, what support is available after discharge, whether the center coordinates referrals, and what it does when a person needs a higher level of care. For a structured way to keep those questions separate from promotional promises, the site’s decision-support materials can help organize a side-by-side comparison.

Ask how the center records adverse events and responds to scrutiny.

Ask whether the center maintains records of adverse events, emergency transfers, and deaths; how events are reviewed; whether mortality reporting is addressed in policy; and what it can disclose about inspection, accreditation, or third-party review history. The answer may have limits because of privacy and legal considerations, but a responsible response should explain the limits rather than dismiss the question.

Also ask for the referral network in practical terms: which hospital-level resources are considered, how transport is arranged, who communicates in an emergency, and what happens after transfer. A referral relationship is not the same thing as onsite capacity, so record both answers separately.

Three questions to keep in the file.